The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Could a virtual reality headset offer a cheaper, easier, and more comfortable method of testing a person's vision, ...
By: Jed Assam MD, Founder and Vitreoretinal Surgeon, VRA Vision Age-related macular degeneration (AMD) is one of the leading causes of vision loss among ...
What is laser photocoagulation? A laser procedure that seals leaking blood vessels to slow vision loss in wet age-related ...
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows. Health care providers for decades have measured ...
Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...
Given just how much lifestyle disorders or non-communicable diseases are on the rise these days, it is quite likely that you would have taken a liver function test (LFT) and then consulted the doctor ...
F or decades, people with advanced age-related macular degeneration (AMD) — the leading cause of irreversible blindness in older adults — have been told that once vision is lost, it’s gone forever.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results